MedicalJane

JUNE 29, 2018

Use of CBD in seizure prevention is well-documented with research ; and now, after conducting its own trials, the FDA appears to agree. Epidiolex’s effectiveness was studied in three randomized, double-blind, placebo-controlled clinical trials involving 516 patients with either Lennox-Gastaut syndrome or Dravet syndrome.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

Canna Law Blog

JANUARY 3, 2023

Until recently, CBD resided in a legal penumbra where hemp was still scheduled on the federal Controlled Substances Act and could not be cultivated without a permit from the Drug Enforcement Administration (“DEA”). And marketing any bodily or curative effects of CBD was (and still is) off limits. 2018 Farm Bill.

CBD 75

CBD Food Clinical Trials Pets 75

Cannabis Law Report

JULY 9, 2021

This article provides an overview of the current state of legality of common psychedelic substances, and some of the potential therapeutic uses to which psychedelics may be applied. As part of the same state-wide initiative, Oregon legalized the use of psilocybin for medical purposes. Drug Enforcement Agency (“DEA”).

Law 105

Law Therapy Clinical Trials Research and Development 105

Veriheal

AUGUST 31, 2020

Program between St. About Sinibaldo: Sinibaldo is an aspiring healthcare professional and a biomedical researcher in the Medical Scientist Training Program (M.D./Ph.D.) Her impressive background includes working in medical dispensaries in Los Angeles under Prop 215 in and prior to legalization and regulation under Prop 64.

Research and Development 117

Research and Development Education Agriculture Patients 117

CannaMD

AUGUST 8, 2020

But CBD’s real calling card is that it’s popularly isolated from marijuana’s sibling plant, hemp , and can be legally sold (in most states) under much more relaxed regulations. One big myth is that the Farm Bill makes hemp-derived CBD legal. However, there are a number of restrictions. CBD Scheduling Rule Change.

CBD 99

CBD DEA Research and Development Hemp 99

Cannabis Law Report

MARCH 2, 2020

The global march toward cannabis legalization has seemingly awoken another long dormant area of scientific interest: psychedelics as medicine. Psychedelic medicine offers investors several key advantages over legal cannabis. Any approved medicines will have to be rescheduled by the Drug Enforcement Administration (DEA).

Medicine 59

Medicine Therapy DEA Pharmaceutical 59

SpeedWeed

MARCH 5, 2021

One, they have been determined by the US Food and Drug Administration to be clinically safe and effective treatments for a specific medical condition. Two, they are federally classified by DEA and HHS as Schedule II, III, IV or V substances. Rescheduling cannabis will not necessarily facilitate clinical research.

Business 52

Business Policy Clinical Trials Research and Development 52

Veriheal

JUNE 29, 2021

In order to legally access other therapies including nature-based options such as psilocybin , you must gain access under a Right to Try law which requires you to have a terminal condition. The FDA refers to this program as the expanded access program on their website.

Therapy 53

Therapy DEA Patients Clinical Trials 53

Cannabis Law Report

JUNE 4, 2021

If the Federal Analogue Rule were to be more strictly enforced, then this may be the only pathway to legally sell Delta-8. In 1996, California legalized medical cannabis yet today, with 37 US States allowing for medical cannabis sales, we still do not have an overall comprehensive cannabis/cannabinoid education program.

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

Canna Law Blog

MAY 7, 2020

Ole Miss got the cannabis study and research cultivation gig from the DEA (via a contract with the National Institute on Drug Abuse (NIDA)) in 1968. This was before implementation of the federal government’s Compassionate Investigational New Drug Program (CINDP), which Ole Miss’s grow now serves in addition to its research.

DEA 70

DEA Research and Development Cultivation Supply Chain 70

Cannabis Law Report

APRIL 13, 2022

Complementary businesses combine to create a preeminent North American platform with operations spanning 13 wellness clinics, four research sites and one bioanalytical laboratory. Hosting clinical trials for MDMA ( MAPS Public Benefit Corporation), psilocybin (the Usona Institute), LSD (MindMed) and ketamine (the University of Utah ).

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

CannaMD

NOVEMBER 15, 2020

A country’s legalization status has a direct influence on where the funds go. In Canada, recreational marijuana use was legalized in October 2018. As such, universities such as McMaster University and McGill University , among others, have built dedicated and comprehensive research programs. or worldwide legalization.

DEA 105

DEA Clinical Trials Cannabinoids Treatment 105

Cannabis Law Report

APRIL 8, 2022

as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. Now, we are closer than ever to legalizing MDMA-assisted therapy for posttraumatic stress disorder (PTSD), though there is still a long road ahead. Rick Doblin, Ph.D., Rick Doblin, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

SpeedWeed

DECEMBER 28, 2018

My personal year in cannabis began on New Year’s Day, when I waited in line along with countless other Californians to buy some cannabis on the first day of legal adult-use sales. Or that Thailand is blazing a trail in Asia—where cannabis laws are often draconian and harshly enforced—by legalizing medical use ( yes! ).

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

NORML

SEPTEMBER 20, 2019

We also spoke with her attorneys, who explained why they believed the DEA broke the law by holding up long-promised medical marijuana research licenses. Essentially, the federal government has monopolized cannabis research, and ElSohly’s product, according to some scientists who’ve seen it, is unsuitable for clinical trials.

DEA 226

DEA Research and Development Clinical Trials Patients 226

Cannabis Law Report

JANUARY 14, 2020

Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research. Similar to the MORE Act, this bill from Representative Hakeem Jeffries (D-New York) would also remove marijuana and THC from the list of Schedule I drugs and create a grant program for states and local governments “for marijuana conviction expungement programs.”

Clinical Trials 69

Clinical Trials Programs Access DEA 69